- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Gainers
- Geovax Labs GOVX stock moved upwards by 74.65% to $7.51. The market value of their outstanding shares is at $47.5 million.
- Agile Therapeutics AGRX shares rose 13.44% to $1.07. The market value of their outstanding shares is at $99.5 million.
- InVivo Therapeutics Hldg NVIV shares increased by 13.36% to $0.76. The company's market cap stands at $25.8 million.
- Marker Therapeutics MRKR stock rose 12.49% to $1.89. The market value of their outstanding shares is at $157.0 million.
- GBS GBS shares moved upwards by 8.85% to $2.95. The market value of their outstanding shares is at $36.5 million.
Losers
- Progenity PROG shares decreased by 49.96% to $0.75 during Friday's pre-market session. The market value of their outstanding shares is at $59.2 million.
- Sonnet BioTherapeutics SONN shares fell 45.09% to $0.67. The company's market cap stands at $14.3 million. As per the news, the Q3 earnings report came out 4 days ago.
- Ensysce Biosciences ENSC shares declined by 13.58% to $3.31. The market value of their outstanding shares is at $80.2 million.
- Fate Therapeutics FATE shares declined by 11.25% to $76.0. The company's market cap stands at $7.2 billion.
- Salarius Pharmaceuticals SLRX stock decreased by 9.56% to $0.82. The market value of their outstanding shares is at $36.6 million.
- Endo International ENDP stock fell 8.74% to $3.24. The market value of their outstanding shares is at $756.5 million.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in